| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 78.28B | 76.24B | 81.02B | 82.35B | 81.47B | 80.82B |
| Gross Profit | 11.21B | 10.41B | 10.62B | 10.90B | 12.35B | 12.99B |
| EBITDA | 6.44B | 3.88B | 3.89B | 4.55B | 5.61B | 5.66B |
| Net Income | 2.67B | 2.06B | 2.11B | 2.76B | 3.52B | 3.42B |
Balance Sheet | ||||||
| Total Assets | 128.85B | 133.39B | 122.00B | 120.93B | 114.97B | 107.46B |
| Cash, Cash Equivalents and Short-Term Investments | 48.98B | 54.34B | 57.92B | 60.94B | 61.30B | 57.87B |
| Total Debt | 43.83B | 44.31B | 35.31B | 32.41B | 32.12B | 29.24B |
| Total Liabilities | 60.11B | 64.22B | 54.58B | 55.12B | 50.84B | 45.89B |
| Stockholders Equity | 67.58B | 68.06B | 67.20B | 65.72B | 64.03B | 61.43B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -5.53B | -617.91M | 609.99M | 383.27M | 11.86B |
| Operating Cash Flow | 0.00 | -5.42B | -374.81M | 789.82M | 840.14M | 11.98B |
| Investing Cash Flow | 0.00 | 2.99B | -1.68B | -541.63M | -2.48B | -7.28B |
| Financing Cash Flow | 0.00 | 3.39B | -1.04B | -1.34B | 1.85B | -1.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥100.60B | 14.61 | ― | 3.08% | -6.27% | -11.07% | |
74 Outperform | ¥114.41B | 5.88 | ― | 2.93% | 20.83% | 57.13% | |
73 Outperform | ¥133.18B | 20.19 | 15.81% | 2.93% | 84.20% | 137.87% | |
71 Outperform | ¥94.77B | 14.58 | ― | 2.19% | 4.72% | 47.55% | |
67 Neutral | ¥34.30B | 18.57 | 5.90% | 3.07% | 3.04% | 44.65% | |
67 Neutral | ¥82.75B | 11.54 | ― | ― | 127.32% | -22.79% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% |